LONG-TERM OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: INSIGHTS ON PROGNOSTIC FACTORS AND VALVE DURABILITY FROM THE CANADIAN MULTICENTER EXPERIENCE

LONG-TERM OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: INSIGHTS ON PROGNOSTIC FACTORS AND VALVE DURABILITY FROM THE CANADIAN MULTICENTER EXPERIENCE

The predictors of late mortality were chronic obstructive pulmonary disease (HR: 1.99, 95% CI: 1.34-2.95), chronic kidney disease (HR: 1.62, 95% CI: 1.09-2.41), chronic atrial fibrillation (HR: 1.82, 95% CI: 1.24-2.67) and frailty (HR: 1.76, 95% CI: 1.17-2.64).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E10-E10
Hauptverfasser: Rodes-Cabau, Josep, Webb, John, Cheung, Anson, Ye, Jian, Dumont, Eric, Chris, Feindel, Osten, Mark, Natarajan, Madhu, Velianou, James L, Martucci, Giussepe, DeVarennes, Benoit, Thompson, Chris R, Chisholm, Robert, Peterson, Mark, Lichtenstein, Samuel, Toggweiler, Stefan, Doyle, Daniel, DeLarochelli&egrave, re, Robert, Dumesnil, Jean, Teoh, Kevin, Chu, Victor, Cheema, Asim, Wood, David, Pibarot, Philippe, Horlick, Eric
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Internal Medicine
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The predictors of late mortality were chronic obstructive pulmonary disease (HR: 1.99, 95% CI: 1.34-2.95), chronic kidney disease (HR: 1.62, 95% CI: 1.09-2.41), chronic atrial fibrillation (HR: 1.82, 95% CI: 1.24-2.67) and frailty (HR: 1.76, 95% CI: 1.17-2.64).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60011-4